Skip to main content
. 2021 Aug 9;10:100035. doi: 10.1016/j.iotech.2021.100035

Table 2.

Mutations per Polycomb repressive complex 2 (PRC2) gene in tumor samples of patients treated with immune checkpoint inhibitors (discovery cohort)

PRC2 gene Missense Truncating Inframe Splice Structural variant/fusion
EZH2 (2.4%) 29 6 2 3 0
EZH1 (1.2%) 4 0 0 0 1
SUZ12 (0.9%) 14 2 0 0 0
EED (0.7%) 9 2 1 0 1